{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:17:55Z","timestamp":1788556675698,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T00:00:00Z","timestamp":1467072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T00:00:00Z","timestamp":1467072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Anxiety disorders are highly comorbid with each other and with other serious mental disorders. As our field progresses, we have the opportunity to pursue treatment study designs that consider these comorbidities. In this perspective review, we first characterized the prevalence of multiple anxiety disorder comorbidity by reanalyzing national survey data, then conducted an English-language PubMed search of studies analyzing the impact of exclusion criteria on treatment outcome data. In the prevalence data, 60% of people with an anxiety disorder had one or more additional anxiety or depression diagnosis. Because our commonly applied exclusion criteria focus on a single diagnosis and do not consider a multiple comorbidity profile, the impact of the criteria may be to exclude up to 92% of anxiety disorder treatment seekers. Moreover, the findings do not suggest a consistent relationship between the number of exclusion criteria and the effect size of treatment outcomes. Thus, future studies might consider a more trans-diagnostic rationale for determining exclusion criteria, one that is generalizable to real-world settings in which multiple diagnoses commonly co-occur. The findings also encourage a more systematic reporting of rationales for the choice of\u2014and the implications of\u2014each exclusion criterion.<\/jats:p>","DOI":"10.1038\/tp.2016.108","type":"journal-article","created":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T18:04:09Z","timestamp":1467137049000},"page":"e847-e847","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["A trans-diagnostic review of anxiety disorder comorbidity and the impact of multiple exclusion criteria on studying clinical outcomes in anxiety disorders"],"prefix":"10.1038","volume":"6","author":[{"given":"A N","family":"Goldstein-Piekarski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L M","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,28]]},"reference":[{"key":"BFtp2016108_CR1","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE . Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593\u2013602.","journal-title":"Arch Gen Psychiatry"},{"key":"BFtp2016108_CR2","unstructured":"Substance Abuse and Mental Health Services Administration Results from the 2012 National Survey on Drug Use and Health: Mental Health Findings. Rockville, MD, USA, 2013."},{"key":"BFtp2016108_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1177\/070674370605100206","volume":"51","author":"JM Somers","year":"2006","unstructured":"Somers JM, Goldner EM, Waraich P, Hsu L . Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Can J Psychiatry 2006; 51: 100\u2013113.","journal-title":"Can J Psychiatry"},{"key":"BFtp2016108_CR4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1001\/archpsyc.1997.01830160021003","volume":"54","author":"MM Weissman","year":"1997","unstructured":"Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG et al. The cross-national epidemiology of panic disorder. Arch Gen Psychiatry 1997; 54: 305\u2013309.","journal-title":"Arch Gen Psychiatry"},{"key":"BFtp2016108_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/wps.20038","volume":"12","author":"P Cuijpers","year":"2013","unstructured":"Cuijpers P, Sijbrandij M, Koole SL, Andersson G, Beekman AT, Reynolds CF 3rd . The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons. World Psychiatry 2013; 12: 137\u2013148.","journal-title":"World Psychiatry"},{"key":"BFtp2016108_CR6","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1176\/appi.ajp.2010.09091379","volume":"167","author":"T Insel","year":"2010","unstructured":"Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 2010; 167: 748\u2013751.","journal-title":"Am J Psychiatry"},{"key":"BFtp2016108_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/wps.20087","volume":"13","author":"BN Cuthbert","year":"2014","unstructured":"Cuthbert BN . The RDoC framework: facilitating transition from ICD\/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry 2014; 13: 28\u201335.","journal-title":"World Psychiatry"},{"key":"BFtp2016108_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1741-7015-11-126","volume":"11","author":"BN Cuthbert","year":"2013","unstructured":"Cuthbert BN, Insel TR . Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med 2013; 11: 126.","journal-title":"BMC Med"},{"key":"BFtp2016108_CR9","volume-title":"21st Century Global Mental Health","author":"E Sorel","year":"2013","unstructured":"Sorel E . 21st Century Global Mental Health. Jones & Bartlett Learning: Boston, MA, USA, 2013."},{"key":"BFtp2016108_CR10","first-page":"1058","volume":"2","author":"MA Halvorson","year":"2015","unstructured":"Halvorson MA, Humphreys K . A review of the nature and impact of exclusion criteria in depression treatment outcome research. Ann Depress Anxiety 2015; 2: 1058.","journal-title":"Ann Depress Anxiety"},{"key":"BFtp2016108_CR11","first-page":"1","volume":"20","author":"K Humphreys","year":"2014","unstructured":"Humphreys K . A review of the impact of exclusion criteria on the generalizability of schizophrenia treatment research. Clin Schizophr Relat Diagn 2014; 20: 1\u201325.","journal-title":"Clin Schizophr Relat Diagn"},{"key":"BFtp2016108_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/PRA.0000000000000082","volume":"21","author":"SH Preskorn","year":"2015","unstructured":"Preskorn SH, Macaluso M, Trivedi M . How commonly used inclusion and exclusion criteria in antidepressant registration trials affect study enrollment. J Psychiatr Pract 2015; 21: 267\u2013274.","journal-title":"J Psychiatr Pract"},{"key":"BFtp2016108_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/mpr.167","volume":"13","author":"RC Kessler","year":"2004","unstructured":"Kessler RC, Berglund P, Chiu WT, Demler O, Heeringa S, Hiripi E et al. The US National Comorbidity Survey Replication (NCS-R): design and field procedures. Int J Methods Psychiatr Res 2004; 13: 69\u201392.","journal-title":"Int J Methods Psychiatr Res"},{"key":"BFtp2016108_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/mpr.166","volume":"13","author":"RC Kessler","year":"2004","unstructured":"Kessler RC, Merikangas KR . The National Comorbidity Survey Replication (NCS-R): background and aims. Int J Methods Psychiatr Res 2004; 13: 60\u201368.","journal-title":"Int J Methods Psychiatr Res"},{"key":"BFtp2016108_CR15","unstructured":"R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2008. ISBN 3-900051-07-0. Available at: http:\/\/www.R-project.org.s."},{"key":"BFtp2016108_CR16","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1176\/appi.ajp.162.2.214","volume":"162","author":"R Bradley","year":"2005","unstructured":"Bradley R, Greene J, Russ E, Dutra L, Westen D . A multidimensional meta-analysis of psychotherapy for PTSD. Am J Psychiatry 2005; 162: 214\u2013227.","journal-title":"Am J Psychiatry"},{"key":"BFtp2016108_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/01.pra.0000442936.23457.5b","volume":"20","author":"JM Ronconi","year":"2014","unstructured":"Ronconi JM, Shiner B, Watts BV . Inclusion and exclusion criteria in randomized controlled trials of psychotherapy for PTSD. J Psychiatr Pract 2014; 20: 25\u201337.","journal-title":"J Psychiatr Pract"},{"key":"BFtp2016108_CR18","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.cpr.2004.08.004","volume":"24","author":"KT Eddy","year":"2004","unstructured":"Eddy KT, Dutra L, Bradley R, Westen D . A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder. Clin Psychol Rev 2004; 24: 1011\u20131030.","journal-title":"Clin Psychol Rev"},{"key":"BFtp2016108_CR19","first-page":"39","volume":"26","author":"BL Odlaug","year":"2014","unstructured":"Odlaug BL, Weinhandl E, Mancebo MC, Mortensen EL, Eisen JL, Rasmussen SA et al. Excluding the typical patient: thirty years of pharmacotherapy efficacy trials for obsessive-compulsive disorder. Ann Clin Psychiatry 2014; 26: 39\u201346.","journal-title":"Ann Clin Psychiatry"},{"key":"BFtp2016108_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jad.2012.09.023","volume":"146","author":"N Hoertel","year":"2013","unstructured":"Hoertel N, Le Strat Y, De Maricourt P, Limosin F, Dubertret C . Are subjects in treatment trials of panic disorder representative of patients in routine clinical practice? Results from a national sample. J Affect Disord 2013; 146: 383\u2013389.","journal-title":"J Affect Disord"},{"key":"BFtp2016108_CR21","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/da.21937","volume":"29","author":"N Hoertel","year":"2012","unstructured":"Hoertel N, Le Strat Y, Blanco C, Lavaud P, Dubertret C . Generalizability of clinical trial results for generalized anxiety disorder to community samples. Depress Anxiety 2012; 29: 614\u2013620.","journal-title":"Depress Anxiety"},{"key":"BFtp2016108_CR22","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0887-6185(03)00040-9","volume":"18","author":"TM Lincoln","year":"2004","unstructured":"Lincoln TM, Rief W . How much do sample characteristics affect the effect size? An investigation of studies testing the treatment effects for social phobia. J Anxiety Disord 2004; 18: 515\u2013529.","journal-title":"J Anxiety Disord"},{"key":"BFtp2016108_CR23","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/JCP.0000000000000204","volume":"34","author":"N Hoertel","year":"2014","unstructured":"Hoertel N, de Maricourt P, Katz J, Doukhan R, Lavaud P, Peyre H et al. Are participants in pharmacological and psychotherapy treatment trials for social anxiety disorder representative of patients in real-life settings? J Clin Psychopharmacol 2014; 34: 697\u2013703.","journal-title":"J Clin Psychopharmacol"},{"key":"BFtp2016108_CR24","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1037\/0022-006X.68.4.594","volume":"68","author":"ME Franklin","year":"2000","unstructured":"Franklin ME, Abramowitz JS, Kozak MJ, Levitt JT, Foa EB . Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with nonrandomized samples. J Consult Clin Psychol 2000; 68: 594\u2013602.","journal-title":"J Consult Clin Psychol"},{"key":"BFtp2016108_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1053\/comp.2002.30803","volume":"43","author":"MR Mavissakalian","year":"2002","unstructured":"Mavissakalian MR, Guo S . Predictors of entering a long-term drug treatment study of panic disorder. Compr Psychiatry 2002; 43: 88\u201394.","journal-title":"Compr Psychiatry"},{"key":"BFtp2016108_CR26","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1037\/0022-006X.69.6.875","volume":"69","author":"D Westen","year":"2001","unstructured":"Westen D, Morrison K . A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies. J Consult Clin Psychol 2001; 69: 875\u2013899.","journal-title":"J Consult Clin Psychol"},{"key":"BFtp2016108_CR27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0005-7967(94)E0027-G","volume":"33","author":"HR Juster","year":"1995","unstructured":"Juster HR, Heimberg RG, Engelberg B . Self selection and sample selection in a treatment study of social phobia. Behav Res Ther 1995; 33: 321\u2013324.","journal-title":"Behav Res Ther"},{"key":"BFtp2016108_CR28","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/S0005-7967(03)00038-X","volume":"41","author":"TM Lincoln","year":"2003","unstructured":"Lincoln TM, Rief W, Hahlweg K, Frank M, von Witzleben I, Schroeder B et al. Effectiveness of an empirically supported treatment for social phobia in the field. Behav Res Ther 2003; 41: 1251\u20131269.","journal-title":"Behav Res Ther"},{"key":"BFtp2016108_CR29","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/00005053-200108000-00008","volume":"189","author":"CL Franklin","year":"2001","unstructured":"Franklin CL, Zimmerman M . Posttraumatic stress disorder and major depressive disorder: investigating the role of overlapping symptoms in diagnostic comorbidity. J Nerv Ment Dis 2001; 189: 548\u2013551.","journal-title":"J Nerv Ment Dis"},{"key":"BFtp2016108_CR30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1037\/0022-006X.76.2.259","volume":"76","author":"KT Mueser","year":"2008","unstructured":"Mueser KT, Rosenberg SD, Xie H, Jankowski MK, Bolton EE, Lu W et al. A randomized controlled trial of cognitive-behavioral treatment for posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol 2008; 76: 259\u2013271.","journal-title":"J Consult Clin Psychol"},{"key":"BFtp2016108_CR31","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1097\/01.aids.0000189866.67182.f7","volume":"19","author":"M Gandhi","year":"2005","unstructured":"Gandhi M, Ameli N, Bacchetti P, Sharp GB, French AL, Young M et al. Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols. Aids 2005; 19: 1885\u20131896.","journal-title":"Aids"},{"key":"BFtp2016108_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/0003-4819-137-1-200207020-00007","volume":"137","author":"CP Gross","year":"2002","unstructured":"Gross CP, Mallory R, Heiat A, Krumholz HM . Reporting the recruitment process in clinical trials: who are these patients and how did they get there? Ann Intern Med 2002; 137: 10\u201316.","journal-title":"Ann Intern Med"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tp2016108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp2016108","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp2016108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T08:39:25Z","timestamp":1672821565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp2016108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,28]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6]]}},"alternative-id":["BFtp2016108"],"URL":"https:\/\/doi.org\/10.1038\/tp.2016.108","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,28]]},"assertion":[{"value":"18 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LMW was a consultant for Humana. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}